Patents by Inventor Adam Zhang
Adam Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240155071Abstract: A method and system for text-to-video generation. The method includes receiving a text input, generating a representation frame based on the text input using a model trained on text-image pairs, generating a set of frames based on the representation frame and a first frame rate, interpolating the set of frames to a higher frame rate, generating a first video based on the interpolated set of frames, increasing a resolution of the first video based on a first and second super-resolution model, and generating an output video based on a result of the super-resolution models.Type: ApplicationFiled: September 29, 2023Publication date: May 9, 2024Inventors: Sonal Gupta, Adam Polyak, Thomas Falstad Hayes, Xi Yin, Jie An, Chao Yang, Oron Ashual, Oran Gafni, Devi Niru Parikh, Yaniv Nechemia Taigman, Uriel Singer, Songyang Zhang, Qiyuan Hu
-
Publication number: 20240148905Abstract: The disclosure features compositions and methods for treating subjects 25 years of age or older having biallelic mutations in otoferlin (OTOF) by way of OTOF gene therapy. The disclosure provides a variety of compositions that include a first nucleic acid vector that contains a polynucleotide encoding an N-terminal portion of an OTOF protein and a second nucleic acid vector that contains a polynucleotide encoding a C-terminal portion of an OTOF protein. These vectors can be used to treat hearing loss or auditory neuropathy in a subject having biallelic OTOF mutations.Type: ApplicationFiled: February 18, 2022Publication date: May 9, 2024Inventors: Adam PALERMO, Ning PAN, Arun SENAPATI, Jonathon WHITTON, Xichun ZHANG
-
Patent number: 11976067Abstract: Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, p, R1, R2, R3, L1, L2, L3, R4, X1, X2, X3, and X4 are as defined herein. Also provided are methods of preparing compounds of formula (II), or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing. Also provided are methods of inhibiting APOL1 and methods of treating an APOL1-mediated disease, disorder, or condition in an individual.Type: GrantFiled: January 17, 2023Date of Patent: May 7, 2024Assignee: Maze Therapeutics, Inc.Inventors: Patrick Sang Tae Lee, Todd Jonathan August Ewing, Adam Neil Reid, Christopher Joseph Sinz, Birong Zhang, Sarah M. Bronner, David John Morgans, Jr., Maarten Hoek, Victoria Anne Assimon, Chris Ziebenhaus, Alexander Wayne Schammel
-
Patent number: 11972338Abstract: This application describes systems and methods for generating machine learning models (MLMs). An exemplary method includes obtaining a sample and user input data characterizing a product or service. A subset of the data is selected from the sample based on sampling the sample according to the user input data. An MLM is trained by applying the data subset as training input to the MLM, thereby providing a trained MLM to emulate a customer selection process unique to the product or service. A user interface (UI) configured to receive other user input data and cause the trained MLM to execute on the other user input data, thereby testing the trained MLM, is presented. A summary of results from the execution of the trained MLM is generated and presented in the UI. The summary of results indicates a contribution to the trained MLM of each of a plurality of features.Type: GrantFiled: May 2, 2023Date of Patent: April 30, 2024Assignee: ZestFinance, Inc.Inventors: David Sheehan, Siavash Yasini, Bingjia Wang, Yunyan Zhang, Qiumeng Yu, Ruochen Zha, Adam Kleinman, Sean Javad Kamkar, Lingzhi Du, Saar Yalov, Jerome Louis Budzik
-
Patent number: 11970480Abstract: Disclosed are compounds having the formula: wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, and R17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.Type: GrantFiled: May 17, 2022Date of Patent: April 30, 2024Assignee: GlaxoSmithKline Intellectual Property Development LimitedInventors: Adam Kenneth Charnley, Michael G. Darcy, Jason W. Dodson, Xiaoyang Dong, Terry V. Hughes, Jianxing Kang, Lara Kathryn Leister, Yiqian Lian, Yue Li, John F. Mehlmann, Neysa Nevins, Joshi M. Ramanjulu, Joseph J. Romano, Gren Z. Wang, Guosen Ye, Daohua Zhang
-
Publication number: 20240136836Abstract: A charger including a vertical section including a first surface, the first surface facing a front direction and including an attachment portion configured to a receive a battery pack, and a horizontal section configured to protrude, in the front direction, from a bottom portion of the vertical section. The charger further including a second surface disposed on the horizontal section, the second surface facing an upward direction, and a fan disposed proximate the horizontal surface, the fan configured to cool the battery pack.Type: ApplicationFiled: October 20, 2022Publication date: April 25, 2024Inventors: Ece Polat, Adam Zwilling, Nicolas James Hanks, Shiyi Zhang, Krishna Sai Teja Kalavala
-
Publication number: 20240131190Abstract: The disclosure features compositions and methods for the treatment of inner ear dysfunction, such as hearing loss or vestibular dysfunction, that reduce inflammatory or cell-mediated immune toxicity in the inner ear, thereby improving transduction and therapeutic efficacy. The disclosure provides a variety of compositions that include a nucleic acid vector that contains a polynucleotide encoding a therapeutic agent operably linked to a ubiquitous promoter and inhibitor of inflammatory or immune cell signaling. The disclosed compositions and methods can be used to increase expression of the therapeutic agent in a subject, such as a human subject suffering from an inner ear dysfunction, while minimizing undesirable immune activation resulting from off-target expression of the target protein in immune cells of the inner ear.Type: ApplicationFiled: February 22, 2022Publication date: April 25, 2024Inventors: Adam PALERMO, Ning PAN, Gabriela PREGERNIG, Jonathon WHITTON, Xichun ZHANG
-
Publication number: 20240132747Abstract: A coated substrate comprising a coating extending over at least a part of the substrate. The coating is obtainable from a coating composition comprising (a) a polymeric binder; and (b) a feathering reducing agent comprising a carboxylic acid reactive functional group. The coated portion of the substrate comprises a pretreatment layer. The pretreatment layer is obtainable from a pretreatment composition that comprises a trivalent chromium compound. The invention extends to a method of coating a pre-treated substrate and a coated package, such as a metal can.Type: ApplicationFiled: January 28, 2022Publication date: April 25, 2024Applicant: PPG Industries Ohio, Inc.Inventors: Adam Bradley Powell, Jr., Elzen Kurpejovic, Fengshuo Hu, Carl A. Seneker, Wenchao Zhang, Hongying Zhou, Edward R. Millero, Jr., Dennis A. Simpson, Michael G. Olah, Rudolf Baumgarten, Kareem Kaleem, Nigel F Masters, William H. Retsch, Jr.
-
Patent number: 11957739Abstract: The present invention provides compositions and methods for treating cancers with reduced or absent CDH1 using a RHOA dominant negative polypeptide or biologically active fragment thereof, and/or a nucleic acid encoding a RHOA dominant negative polypeptide or biologically active fragment thereof.Type: GrantFiled: November 5, 2018Date of Patent: April 16, 2024Assignee: Dana-Farber Cancer Institute, Inc.Inventors: Adam Bass, Haisheng Zhang
-
Patent number: 11960849Abstract: Aspects discussed herein may relate to using machine learning models as part of methods and techniques for ingesting, creating, storing, editing, and managing a document. The document may be a legal contract that includes one or more clauses. Among other things, one or more machine learning models may be configured to recognize clauses and/or classifications, or types, of clauses. For example, the one or more generative language models may be used to generate one or more recommended edits to a clause, generate one or more suggested clauses that are missing from the contract, and/or generate one or more suggested locations where a clause may be inserted into or moved within the contract.Type: GrantFiled: September 14, 2023Date of Patent: April 16, 2024Assignee: Ironclad, Inc.Inventors: Cai GoGwilt, Jennifer S. S. Monteleone, Adam Weber, Yujiao Zhang, Angela Kou, Vidya Ravikumar, Kevin Verdieck, Wolfgang Van HellicksonSabelhaus, Katherine Vilhena, Peter Nam That Ton, Nilay Amit Sadavarte, Sumuk Rao, Jean-Marc Soumet, Alexander S. Gillmor
-
Patent number: 11960387Abstract: A sample ratio mismatch (SRM) analyzer receives data from an online controlled experiment (OCE) and provides information to help determine a root cause of an SRM. The SRM analyzer may identify one or more segments in the data that include an SRM and may determine whether a triggered scorecard of the OCE includes an SRM. The data may include one or more scorecards. The SRM analyzer may determine whether each scorecard has an SRM. The SRM analyzer may test a difference in proportion of users assigned to treatment between a last scorecard without an SRM and a first scorecard with an SRM. If the difference in proportion is statistically meaningful, the SRM analyzer may determine that the SRM arose after the last scorecard. If the difference in proportions is not statistically meaningful, the SRM analyzer may determine that the SRM existed from a beginning of the OCE.Type: GrantFiled: April 1, 2021Date of Patent: April 16, 2024Assignee: Microsoft Technology Licensing, LLCInventors: Aleksander Fabijan, Trevor Craig Blanarik, Kewei Chen, Ruhan Zhang, Adam Marc Gustafson, Venkata Kavitha Budumuri, Stephen James Hunt, Maxwell Campbell Caughron, Vaibhav Kumar Bajpai
-
Publication number: 20240101860Abstract: A coating composition comprising (a) a polyester binder material; and (b) a feathering reducing agent. The feathering reducing agent is selected from (i) an acrylic feathering reducing agent comprising a functional group selected from hydroxyl, epoxide, phosphatized epoxide and/or acid-functional; (ii) a hydroxy-functional polyester feathering reducing agent; (iii) a feathering reducing agent comprising a functional group selected from amine, amide, imine and/or nitrile; (iv) a phosphatized epoxy feathering reducing agent; (v) a phenolic resin feathering reducing agent; and/or (vi) a feathering reducing agent comprising an oxazolyl functional group. The invention extends to a substrate coated with the coating composition and use of the coating composition to reduce feathering.Type: ApplicationFiled: January 28, 2022Publication date: March 28, 2024Applicant: PPG Industries Ohio, Inc.Inventors: Adam Bradley Powell, Jr., Elzen Kurpejovic, Fengshuo Hu, Carl A. Seneker, Wenchao Zhang, Hongying Zhou, Edward R. Millero, Jr., Dennis A. Simpson, Michael G. Olah, Rudolf Baumgarten, Kareem Kaleem, Nigel F Masters, William H. Retsch, Jr.
-
Publication number: 20240090884Abstract: A surgical robot system includes a robot having a robot base and a robot arm coupled to the robot base, and a surgical retractor. The surgical retractor includes a retractor frame, a coupler, blades, a force and/or torque sensor, and a force and/or torque feedback determination unit. The retractor frame includes arms that are translatably and/or pivotably connected to the retractor frame. The coupler releasably attaches the retractor frame to the robot arm. The blades are each coupled to and extend away from a distal end of one of the arms. The force and/or torque sensor is connected to the blades and indicates an amount of force and/or torque being applied to the blades from contact with material of a surgical site. The force and/or torque feedback determination unit determines the amount of force and/or torque being applied to the blades based on the indication.Type: ApplicationFiled: December 1, 2023Publication date: March 21, 2024Inventors: Adam Friedrich, Neil R. Crawford, Kevin Zhang, Sanjay Joshi, Norbert Johnson, Weston Healy
-
Publication number: 20240086479Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, that identify and issue search queries expected to be issued in the future. A set of search queries that have been issued by multiple user devices can be obtained. For each query instance, contextual data can be obtained. A first query and its contextual data can be input to a model that outputs the query's likelihood of being issued in the future. The model can be trained using contextual data for training queries and a corresponding labels for the training queries. The learning model outputs the first query's likelihood of being issued in future, and this query is stored as a repeatable query if the likelihood satisfying a repeatability threshold. Subsequently, a stored repeatable query is issued upon a selection of a user selectable interface component and the search engine provides search results for the query.Type: ApplicationFiled: November 22, 2023Publication date: March 14, 2024Inventors: Yew Jin Lim, David Adam Faden, Mario Tanev, Lauren Ashley Koepnick, Sagar Gandhi, William Ming Zhang
-
Publication number: 20240082319Abstract: Compositions comprising Bacillus pumilis O72NR7 (deposit accession number DSM 32563) are useful for improving myriad performance parameters when fed to animals, including, but not limited to, body weight gain, average daily gain and feed conversion rates. The present disclosure describes animal feed additives and animal feeds comprising Bacillus pumilis O72NR7.Type: ApplicationFiled: October 11, 2023Publication date: March 14, 2024Applicant: Novozymes A/SInventors: Adam Nelson, Erik Eckhardt, Estelle Devillard, Meagan Hale, Emily Zhang, Ethan Chad Baker
-
Publication number: 20240086651Abstract: Aspects discussed herein may relate to using machine learning models as part of methods and techniques for ingesting, creating, storing, editing, and managing a document. The document may be a legal contract that includes one or more clauses. Among other things, one or more machine learning models may be configured to recognize clauses and/or classifications, or types, of clauses. For example, the one or more generative language models may be used to generate one or more recommended edits to a clause, generate one or more suggested clauses that are missing from the contract, and/or generate one or more suggested locations where a clause may be inserted into or moved within the contract.Type: ApplicationFiled: September 14, 2023Publication date: March 14, 2024Inventors: Cai GoGwilt, Jennifer S.S. Monteleone, Adam Weber, Yujiao Zhang, Angela Kou, Vidya Ravikumar, Kevin Verdieck, Wolfgang Van HellicksonSabelhaus, Katherine Vilhena, Peter Nam That Ton, Nilay Amit Sadavarte, Sumuk Rao, Jean-Marc Soumet, Alexander S. Gillmor
-
Patent number: 11926660Abstract: The present disclosure encompasses compositions and methods for effectively treating at least one symptom or sign of Aß plaque or cerebral amyloid angiopathy (CAA) associated symptoms, or for decreasing amyloid plaque load or CAA load. The method comprises administering an effective amount of an anti-ApoE antibody to a mammalian subject, such as to a human.Type: GrantFiled: August 24, 2021Date of Patent: March 12, 2024Assignee: Washington UniversityInventors: David Holtzman, Hong Jiang, Thu Nga Bien-Ly, Mark S. Dennis, Jing Guo, Adam P. Silverman, Ryan J. Watts, Yin Zhang
-
Patent number: 11911857Abstract: Disclosed are apparatus and systems to determine voltage measurements in welding-type applications to facilitate control of welding-type processes. Disclosed systems include a remote operations interface configured to facilitate voltage measurements in welding-type applications and facilitate communication between a welding-type power supply and a wire feeder.Type: GrantFiled: June 3, 2020Date of Patent: February 27, 2024Assignee: Illinois Tool Works Inc.Inventors: Bo Zhang, Adam E. Anders
-
Patent number: 7696551Abstract: A composite hard mask is disclosed that enables sub-100 nm sized MTJ cells to be formed for advanced devices such as spin torque MRAMs. The hard mask has a lower non-magnetic metallic layer such as Ru to magnetically isolate an overlying middle metallic spacer such as MnPt from an underlying free layer. The middle metallic spacer provides a height margin during subsequent processing to avoid shorting between a bit line and the MTJ cell in the final device. An upper conductive layer may be made of Ta and is thin enough to allow a MTJ pattern in a thin overlying photoresist layer to be transferred through the Ta during a fluorocarbon etch without consuming all of the photoresist. The MTJ pattern is transferred through the remaining hard mask layers and underlying MTJ stack of layers with a second etch step using a C, H, and O etch gas composition.Type: GrantFiled: September 20, 2007Date of Patent: April 13, 2010Assignee: MagIC Technologies, Inc.Inventors: Rongfu Xiao, Chyu-Jiuh Torng, Tom Zhang, Witold Kula, Adam Zhang
-
Publication number: 20080170537Abstract: An apparatus and a method for communication processing are disclosed. The apparatus includes a network connecting unit, a wireless connecting unit, and a processing unit. The network connecting unit is for use in connecting with internet and communicating a first communicating signal with the internet. The wireless connecting unit is for use in connecting with a portable communication device and communicating a second communicating signal with the portable communication device through a first communicating connection or a second communicating connection. The processing unit is used for converting the first communicating signal into the second communicating signal and vice versa. When a communication request is received by the communication processing apparatus, an available or a stable communicating connection can be established, such that the possible interruption of the communication can be avoided and the cost of communication is also reduced.Type: ApplicationFiled: January 12, 2007Publication date: July 17, 2008Applicant: INVENTEC APPLIANCES CORP.Inventors: Cheng-Shing Lai, Yong Zheng, Adam Zhang